Skip to main content
Clinical Practice and Cases in Emergency Medicine logoLink to Clinical Practice and Cases in Emergency Medicine
. 2024 Jan 9;8(1):72–73. doi: 10.5811/cpcem.1470

A Case of Perforating Folliculitis in a Peritoneal Dialysis Patient

Glenn Goodwin *,, Katherine L O’Neil *, Megan Dekok , Moshe Bengio *, Philip O Scumpia , Abhishek Roka *, Alexander J Scumpia *
PMCID: PMC10966494  PMID: 38546318

Abstract

Case Presentation

A 30-year-old male with a past medical history of hypertension and renal failure on peritoneal dialysis presented to the emergency department with a chief complaint of a rash on his anterior trunk for the prior three weeks. Dermatological examination revealed multiple, discrete folliculocentric, erythematous, and hyperpigmented papules, with scattered adjacent angulated erosions.

Discussion

Perforating folliculitis is a rare and often difficult to diagnose skin condition classically seen in patients with chronic renal disease or underlying immunodeficiency.

Keywords: case report, peritoneal dialysis, perforating folliculitis


Population Health Research Capsule.

What do we already know about this clinical entity?

Perforating folliculitis is classically seen in patients with chronic renal disease or underlying immunodeficiency.

What is the major impact of the image?

This case highlights the importance of broadening the differential for undifferentiated rashes that present to the emergency department.

How might this improve emergency medicine practice?

Awareness of the association between the patient’s receiving peritoneal dialysis and the development of perforating folliculitis can expedite patient care.

CASE PRESENTATION

A 30-year-old male with a past medical history of hypertension and renal failure on peritoneal dialysis presented to the emergency department (ED) through triage with a chief complaint of a pruritic rash on his anterior trunk for the prior three weeks. The patient had complaints of multiple dark, erythematous, raised, pruritic lesions on the lower chest and anterior abdomen. He denied any new exposures, new medications, or recent travel. Symptomatic management was not initiated prior to presenting to the ED. The patient also denied associated systemic symptoms. Routine laboratory results were within normal limits. Dermatological examination revealed multiple, discrete folliculocentric, erythematous, and hyperpigmented papules with scattered adjacent angulated erosions (Image). The rash spared mucosal surfaces with no signs of contiguous spread onto the limbs, palms, or soles.

Image.

Image.

30-year-old male with multiple, discrete folliculocentric, erythematous, and hyperpigmented papules on the anterior chest consistent with perforating folliculitis (arrow).

DISCUSSION

Perforating disorders are characterized by transepidermal extrusion of altered keratin or other dermal connective tissue products and include four main conditions; however, the secondary form of this collection of diseases is regarded as acquired perforating dermatosis (APD) 1 , 2 The only way to differentiate among the four conditions is through histopathological assessment, but clinical diagnosis of APD is often sufficient in the setting of a phenotypical assessment of the lesions along with the patient having diabetes and/or chronic renal failure. 2 Other common associated comorbidities include diabetes, vitamin A deficiency, and HIV. 2 4

The diagnosis of perforating folliculitis can be challenging. Emergency physicians are trained to recognize well-known, life-threatening rashes; however, they must also be cognizant of more benign rashes. While not life-threatening, these rashes can be debilitating and cause severe patient discomfort, necessitating accurate diagnosis to administer proper care and management. Our patient was treated with topical 0.1% triamcinolone lotion and given outpatient dermatology follow-up upon discharge from the ED. Perforating folliculitis is often treated with systemic or topical corticosteroids, retinoids, and keratolytic agents such as urea or salicylic acid. 5 The pruritic symptoms are often treated with emollients and oral antihistamines. 5

Footnotes

Section Editor: Manish Amin, DO

Full text available through open access at http://escholarship.org/uc/uciem_cpcem

Conflicts of Interest: By the CPC-EM article submission agreement, all authors are required to disclose all affiliations, funding sources and financial or management relationships that could be perceived as potential sources of bias. The authors disclosed none.

Patient consent has been obtained and filed for the publication of this case report.

REFERENCES

  • 1.Fernandes KA, Lima LA, Guedes JC, et al. Acquired perforating dermatosis in a patient with chronic renal failure. An Bras Dermatol. 2016;91(5 suppl 1):10–3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Rapini RP, Herbert AA, Drucker CR. Acquired perforating dermatosis. Evidence for combined transepidermal elimination of both collagen and elastic fibers. Arch Dermatol. 1989;125(8):1074–8. [DOI] [PubMed] [Google Scholar]
  • 3.Hudson RD and Apisarnthanarax P . Renal failure and perforating folliculitis. JAMA. 1982;247(14):1936. [PubMed] [Google Scholar]
  • 4.Neill SM, Pembroke AC, du Vivier AW, et al. Phrynoderma and perforating folliculitis due to vitamin A deficiency in a diabetic. J R Soc Med. 1988;81(3):171–2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Haseer Koya H, Ananthan D, Varghese D, Njeru M, Curtiss C, Khanna A. Acquired reactive perforating dermatosis: a rare skin manifestation in end stage renal disease. Nephrology (Carlton). 2014;19(8):515–6. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Practice and Cases in Emergency Medicine are provided here courtesy of Department of Emergency Medicine, University of California Irvine

RESOURCES